American Society of Clinical Oncology is working to develop a clinical decision support and analytics tool to improve delivery of care to patients with cancer.
The platform, CancerLinQ, is scheduled for release in late 2015. So far, eight oncology practices around the U.S. have signed agreements with CancerLinQ to provide patient records for the first version of CancerLinQ. These include Inova Comprehensive Cancer & Research Institute, South Coast Centers for Cancer Care, New England Cancer Specialists, Medical Oncology Hematology Consultants, PA Cancer Treatment Centers of America, Marin Cancer Care, Space Coast Cancer Center and Michiana Hematology-Oncology, according to a press release.
These practices, which include community practices and large cancer centers, have engaged CancerLinQ to aggregate and analyze a wide range of data and provide reports for quality improvement. Insights gathered from the data will establish the groundwork for developing the full system, which will be open to all U.S. oncology practices, according to ASOC.
CancerLinQ LLC will continue to advance the overall development of the platform, while ASCO will maintain control over the data, service, and products that stem from the platform including clinical decision support tools and analyses.